Prophylactic Oophorectomy for Reducing Ovarian Cancer Risk

Video

For High-Definition, Click

Prophylactic bilateral salpingo-oophorectomy is the best strategy for reducing the risk of ovarian cancer in BRCA-positive women, notes Warner K. Huh, MD. Risk is reduced by over 90% in high-risk individuals, adds Robert A. Burger, MD. However, the reduction in risk of ovarian cancer is accompanied by early menopause, and women should receive appropriate counseling, remarks Huh.

Burger comments that treatments (eg, hormone replacement therapy) are available to address symptoms of menopause. Patients receiving hormone therapy should be monitored appropriately; there is no evidence an increased risk of metabolic or other lifelong medical consequences of hormone replacement with careful monitoring.

Due to the increased risk of breast cancer associated with these genetic abnormalities, patients who undergo oophorectomy and receive hormone replacement therapy may also require prophylactic mastectomies, notes Michael J. Birrer, MD.

James Tate Thigpen, MD, highlights the importance of educating patients that the risk for the development of ovarian cancer does not drop to zero after oophorectomy, as ovarian neoplasms can arise elsewhere in the abdominal cavity.

Related Videos
Michael Richardson, MD
Gottfried Konecny, MD
Arya Amini, MD
Gottfried E. Konecny, MD, lead clinician, gynecologic oncology, Department of Medicine, the University of California, Los Angeles
Adrianna Masters, MD, PhD,
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine